Intrinsic Value of S&P & Nasdaq Contact Us

M3, Inc. MTHRY OTC

Other OTC • Healthcare • Medical - Healthcare Information Services • JP • USD

SharesGrow Score
79/100
4/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

M3, Inc. (MTHRY) trades at a trailing P/E of 0.2. Trailing earnings yield is 588.24%.

Criteria proven by this page:

  • VALUE (100/100, Pass) — P/E is below market average (0.2); earnings yield beats bond yields (588.24%).
  • Trailing Earnings Yield 588.24% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.

Overall SharesGrow Score: 77/100 with 4/7 criteria passed.

SharesGrow 7-Criteria Score
79/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
N/A
No coverage
PAST
100/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
MOAT
73/100
→ Income
~
GROWTH
48/100
→ Income
~
INCOME
55/100
→ Income

Valuation Snapshot — MTHRY

Valuation Multiples
P/E (TTM)0.2
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.02
EV/EBITDA0.0
Per Share Data
EPS (TTM)$29.80
Book Value / Share$0.00
Revenue / Share$209.72
FCF / Share$0.00
Yields & Fair Value
Earnings Yield588.24%
Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $9.65 $64.66B $12.51B 19.3%
2017 $12.35 $78.14B $16B 20.5%
2018 $13.99 $94.47B $18.13B 19.2%
2019 $15.10 $113.06B $19.58B 17.3%
2020 $15.94 $130.97B $21.64B 16.5%
2021 $27.84 $169.2B $37.82B 22.4%
2022 $46.99 $208.16B $63.85B 30.7%
2023 $36.09 $230.82B $49.03B 21.2%
2024 $33.32 $238.88B $45.27B 19%
2025 $29.80 $284.9B $40.48B 14.2%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message